Health Canada has announced that at its request, the distribution of ranitidine drugs, which are used to treat heartburn – by prescription and over the counter – be stopped while Health Canada assesses a potential health risk. Students who use this drug are advised to consult with a pharmacist. For more information, visit Health Canada’s website.
According to the announcement: "The request to stop distribution means that the existing stock of ranitidine products currently available in pharmacies or at retail stores may continue to be sold. This is different from a recall, since products that are being recalled can no longer be sold."
For more detailed information and a complete list of affected products, please visit Health Canada’s website.
If you have concerns about potential complications, please contact Health Services at 519-888-4096.